(Q77750257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

pancreatic adenocarcinoma

8 December 2019

main subject

1 reference

W E Fisher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Muscarella

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L G Boros

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

W J Schirmer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Pancreatology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

169-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

Hormone receptors. An update and application.

8 December 2019

cites work

1 reference

12 December 2020

A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer

1 reference

12 December 2020

Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle

1 reference

12 December 2020

Treatment with Secretin and a Cholecystokinin-Like Peptide in Patients with Pancreatic Cancer

1 reference

12 December 2020

Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research

1 reference

12 December 2020

Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice

1 reference

12 December 2020

Cholecystokinin receptors and PANC-1 human pancreatic cancer cells

1 reference

12 December 2020

Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

1 reference

12 December 2020

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters

1 reference

12 December 2020

Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats

1 reference

12 December 2020

Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma

1 reference

12 December 2020

Studies of the effect of cerulein administration on experimental pancreatic carcinogenesis.

1 reference

12 December 2020

Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors

1 reference

12 December 2020

Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas

1 reference

12 December 2020

Binding of epidermal growth factor in rat pancreatic acini

1 reference

12 December 2020

Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide

1 reference

12 December 2020

Cholecystokinin inhibits pancreatic and hepatic carcinogenesis.

1 reference

12 December 2020

Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study

1 reference

12 December 2020

CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium

1 reference

12 December 2020

Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice

1 reference

12 December 2020

Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.

1 reference

12 December 2020

Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.

1 reference

12 December 2020

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

1 reference

12 December 2020

Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations

1 reference

12 December 2020

Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules

1 reference

12 December 2020

Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice

1 reference

12 December 2020

Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer.

1 reference

12 December 2020

Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats

1 reference

12 December 2020

Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.

1 reference

12 December 2020

Pancreatic carcinogenesis: effect of secretin in the hamster- nitrosamine model

1 reference

12 December 2020

Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide

1 reference

12 December 2020

Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.

1 reference

12 December 2020

Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts

1 reference

12 December 2020

Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth

1 reference

12 December 2020

Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth

1 reference

12 December 2020

Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells

1 reference

12 December 2020

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors

1 reference

12 December 2020

Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990

1 reference

12 December 2020

Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters.

1 reference

12 December 2020

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

12 December 2020

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

1 reference

12 December 2020

Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas

1 reference

12 December 2020

Effects of a high-fat diet and L364,718 on growth of human pancreas cancer

1 reference

12 December 2020

Human pancreatic cancer cell lines do not express receptors for somatostatin

1 reference

12 December 2020

Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat.

1 reference

12 December 2020

Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxopropyl)-amine: cocarcinogenic effect of epidermal growth factor.

1 reference

12 December 2020

Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice

1 reference

12 December 2020

Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters

1 reference

12 December 2020

Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines

1 reference

12 December 2020

Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer

1 reference

12 December 2020

Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice

1 reference

12 December 2020

Evaluation of receptors for somatostatin in various tumors using different analogs.

1 reference

12 December 2020

Membrane receptors for peptides in experimental and human pancreatic cancers

1 reference

12 December 2020

Vasoactive intestinal peptide inhibits the growth of hamster pancreatic cancer but not human pancreatic cancer in vivo

1 reference

12 December 2020

Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation

1 reference

12 December 2020

Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase

1 reference

12 December 2020

Candidate hormones of the gut. I. Introduction

1 reference

12 December 2020

Effects of chronic administration of somatostatin on rat exocrine pancreas

1 reference

12 December 2020

Hormonal control of pancreatic cancer growth

1 reference

12 December 2020

Effect of secretin on pancreatic carcinogenesis in the hamster model.

1 reference

12 December 2020

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

1 reference

12 December 2020

Effects of sandostatin and castration on pancreatic carcinogenesis in rats and hamsters

1 reference

12 December 2020

Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters

1 reference

12 December 2020

Effect of CCK receptor antagonist on growth of pancreatic adenocarcinoma

1 reference

12 December 2020

Cholecystokinin inhibits DNA alkylation induced by N-nitrosobis (2-oxopropyl)amine (BOP) in hamster pancreas

1 reference

12 December 2020

Pancreastatin and islet hormone release

1 reference

12 December 2020

Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone

1 reference

12 December 2020

Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels

1 reference

12 December 2020

Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model

1 reference

12 December 2020

Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells

1 reference

12 December 2020

Hormonal control of pancreatic growth

1 reference

12 December 2020

Adenocarcinoma of the human exocrine pancreas : Presence of secretin and caerulein receptors

1 reference

12 December 2020

Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8

1 reference

12 December 2020

Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

1 reference

12 December 2020

VIP regulation of a human pancreatic cancer cell line: Capan-1.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02788419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9873951%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference